The global AI in omics studies market involves the application of artificial intelligence techniques to analyze large volumes of genomic, proteomic and metabolomic data to better understand diseases. AI algorithms can process huge datasets, identify patterns and relationships, and generate novel insights to accelerate scientific discovery and precision medicine initiatives. It allows automatic detection of anomalies and biologically relevant patterns, classification of samples, prediction of drug responses and more. The widespread availability of cloud-based AI analytics services has made this technology more accessible to researchers.

The Global AI in Omics Studies Market is estimated to be valued at US$ 639.8 Mn in 2024 and is expected to exhibit a CAGR of 32% over the forecast period 2024 To 2031.

Key Takeaways

Key players: Key players operating in the AI in Omics Studies market include Thermo Fisher Scientific, Agilent Technologies, Illumina, BGI Genomics, Dassault Systèmes, Qiagen, Waters Corporation, GE Healthcare, Amazon Web Services, Inc., Bruker, and Danaher. These companies offer integrated workflow solutions, reagents, software and services for AI-driven omics applications.

Growing demand: The increasing volumes of multi-omic datasets and the need for advanced analytics to accelerate insights is driving significant demand for AI technologies in research. Cloud-based solutions are finding more adoption due to their scalability, cost benefits and support for multi-omics data integration.

Global expansion: Leading market players are investing in AI In Omics Studies Market Growth focused acquisitions and partnerships to expand their geographical presence into emerging markets. North America currently dominates however the Asia Pacific market is expected to register fastest growth owing to increasing R&D expenditures and government funding.

Market drivers

Cloud-based analytics services: The wide availability of cloud-based AI platforms for omics data from leading Service providers such as Amazon Web Services, Microsoft Azure, Google Cloud etc has made these technologies highly accessible. The cloud handles huge storage, computing & analytics requirements and enables collaborative research globally. This is a key driver propelling the adoption of AI in omics studies market.

The growth trajectory of the global AI in omics studies market is highly dependent on geopolitical stability across different regions. Currently, the ongoing Russia-Ukraine conflict and rising political tensions between major economies has introduced significant uncertainties. This has disrupted supply chains and research collaborations. There has been delay and cancellation of omics projects involving labs and researchers from the affected nations. The sanctions have made it difficult to procure key technology components and consumables. These short term hurdles are expected to hamper the adoption of AI solutions in clinical and academic settings for omics applications. However, in the long run, governments and private players are likely to focus on bolstering local manufacturing capabilities and building alternative international partnerships to overcome reliability issues. There is also a possibility of redirecting research funding towards development of new AI algorithms which can work with limited datasets and handle data privacy challenges arising out of geopolitical conflicts. Overall, while political instability poses near term challenges, focused policy measures and innovation could help sustain the healthy growth outlook for this market over the coming decade.

North America currently dominates the global AI in omics studies market and accounts for the largest share in terms of value. This is attributed to presence of major industry players and convenient access to latest technologies in the region. Countries like United States and Canada have seen widespread adoption of AI-driven tools and platforms across different omics domains including genomics, proteomics and metabolomics within academic, biopharma and clinical settings. Availability of high quality omics datasets, trained computational experts and supportive regulatory guidelines have accelerated integration of machine learning in varied omics applications throughout North America. Additionally, significant R&D investments by both public and private sectors have promoted development of AI-based precision diagnostics, population health studies as well as drug discovery initiatives leveraging omics data. This has consolidated North America’s leadership position as the most lucrative market for AI in omics. However, as Asian countries make focused efforts to build local capabilities, the global landscape is expected to diversify over the coming years.

Get more insights on AI In Omics Studies Market